Edward J Gane (Edward Gane, Ed Gane)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Dendritic Cells

Inflammatory Response

Hepatitis B Virus

Top Venues

Antiviral therapy

Journal of viral hepatitis

Liver international : official journal of the International Association for the Study of the Liver

Journal of addictive diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Wim Pierson, Marianne Tuefferd, Florence Herschke, Leen Slaets, Marjolein Crabbe, Dorien Verstappen, Steffi De Pelsmaeker, Ian Strickland, Edward J Gane, Christian Schwabe, Yingjie Zhang, Peter Meerts, Joris Vandenbossche, Pieter Van Remoortere, Inge Verbrugge, An De Creus
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults. Antiviral therapy 28 (3) (2023)
Liviawati S Wu, Yue Hu, Edward J Gane, Leen Slaets, An De Creus, Yanhua Ding, Junqi Niu, Christian Schwabe, Nele Goeyvaerts, Zhongnan Xu, Dandan Huo, Marianne Tuefferd, Inge Verbrugge, Pieter Van Remoortere, Ullrich Schwertschlag, Joris Vandenbossche
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants. Antiviral therapy 28 (1) (2023)
Wim Pierson, Marianne Tuefferd, Florence Herschke, Leen Slaets, Marjolein Crabbe, Dorien Verstappen, Steffi De Pelsmaeker, Ian Strickland, Edward J Gane, Christian Schwabe, Yingjie Zhang, Peter Meerts, Joris Vandenbossche, Pieter Van Remoortere, Inge Verbrugge, An De Creus
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults. Antiviral therapy 28 (3) (2023)
Henry L Y Chan, Maria Buti Ferret, Young-Suk Lim, Kosh Agarwal, Patrick Marcellin, Maurizia Rossana Brunetto, Wan-Long Chuang, Harry L A Janssen, Scott Fung, Namiki Izumi, Dzhamal Abdurakhmanov, Maciej Jabłkowski, Mustafa K Celen, Xiaoli Ma, Florin Caruntu, John F Flaherty, Frida Abramov, Hongyuan Wang, Gregory Camus, Anu Osinusi, Calvin Q Pan, Dr Shalimar, Wai-Kay Seto, Edward J Gane
Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety. The American journal of gastroenterology (2023)
Liviawati S Wu, Yue Hu, Edward J Gane, Leen Slaets, An De Creus, Yanhua Ding, Junqi Niu, Christian Schwabe, Nele Goeyvaerts, Zhongnan Xu, Dandan Huo, Marianne Tuefferd, Inge Verbrugge, Pieter Van Remoortere, Ullrich Schwertschlag, Joris Vandenbossche
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants. Antiviral therapy 28 (1) (2023)
Edward J Gane, Man-Fung Yuen, Thomas N Kakuda, Tetsuro Ogawa, Yasushi Takahashi, Nele Goeyvaerts, Isabelle Lonjon-Domanec, Tamisha Vaughan, Thomas Schluep, James Hamilton, Emmanuel Njumbe Ediage, Vera Hillewaert, Jan Snoeys, Oliver Lenz, Willem Talloen, Michael Biermer
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B. Antiviral therapy 27 (3) (2022)
Fred Poordad, Franco Felizarta, Betty B Yao, J Scott Overcash, Tarek Hassanein, Kosh Agarwal, Edward J Gane, David Shaw, Michael Waters, Preethi Krishnan, Andrew Topp, Margaret Burroughs, Frederik Nevens
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up study. Liver international : official journal of the International Association for the Study of the Liver 42 (6) (2022)
Olav Dalgard, Alain H Litwin, Oren Shibolet, Jason Grebely, Ronald Nahass, Frederick L Altice, Brian Conway, Edward J Gane, Anne F Luetkemeyer, Cheng-Yuan Peng, David Iser, Isaias Noel Gendrano, Michelle M Kelly, Barbara A Haber, Heather L Platt, Amy Puenpatom, null null
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection. Journal of addictive diseases (2022)
Kosh Agarwal, Jia Xu, Edward J Gane, Tuan T Nguyen, Yanhua Ding, Steven J Knox, Katia Alves, Marc Evanchik, Katie Zomorodi, Julie Ma, Ran Yan, Qi Huang, Richard Colonno, Luisa M Stamm, Tarek I Hassanein, Dong Joon Kim, Young Suk Lim, Man-Fung Yuen
Safety, pharmacokinetics, and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: a randomized, placebo-controlled Phase 1 study. Journal of viral hepatitis (2022)
Edward J Gane, Victor De Ledinghen, Douglas E Dylla, Giuliano Rizzardini, Mitchell L Shiffman, Stephen T Barclay, Jose Luis Calleja, Zhenyi Xue, Margaret Burroughs, Julio A Gutierrez
Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials. Journal of viral hepatitis 28 (11) (2021)
Betty B Yao, Linda M Fredrick, Gretja Schnell, Kris V Kowdley, Paul Y Kwo, Fred Poordad, Kinh Nguyen, Samuel S Lee, Christophe George, Florence S H Wong, Edward J Gane, Armand Abergel, Catherine W Spearman, Tuan Nguyen, Manh Hung Le, Thuy Tt Pham, Federico Mensa, Asselah Tarik
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
Cameron Schauer, Marius van Rijnsoever, Edward J Gane
Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand. Journal of viral hepatitis 26 (12) (2019)